Page last updated: 2024-08-23

daurisoline and Esophageal Squamous Cell Carcinoma

daurisoline has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Jia, L; Liu, Q; Pan, Y; Wang, F; Xu, T; Yuan, S; Zhang, L1
Dong, Z; Jiang, Y; Li, M; Li, X; Liu, K; Lu, J; Wang, D; Wu, Q; Yu, Y; Yuan, Q; Zhang, W; Zhang, X; Zhao, J; Zhao, L1

Other Studies

2 other study(ies) available for daurisoline and Esophageal Squamous Cell Carcinoma

ArticleYear
Daurisoline Inhibits ESCC by Inducing G1 Cell Cycle Arrest and Activating ER Stress to Trigger Noxa-Dependent Intrinsic and CHOP-DR5-Dependent Extrinsic Apoptosis via p-eIF2
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Activating Transcription Factor 4; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzylisoquinolines; Cell Line, Tumor; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Eukaryotic Initiation Factor-2; G1 Phase Cell Cycle Checkpoints; Humans; Mice; Reactive Oxygen Species; Signal Transduction

2022
Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase.
    Molecular carcinogenesis, 2023, Volume: 62, Issue:4

    Topics: Benzylisoquinolines; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Molecular Docking Simulation; Xenograft Model Antitumor Assays

2023